| Mar 14, 2025 |
Mar 18, 2025 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
17.5
|
-1,857
|
-1.83%
|
✗
|
$1.3M |
| Jun 28, 2024 |
Jul 1, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
36.3
|
-588
|
-0.81%
|
✗
|
$48.4K |
| Apr 30, 2024 |
May 31, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
35.0
|
-4,700
|
-3.15%
|
✓
|
$376K |
| Mar 15, 2024 |
Mar 19, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
17.5
|
-9,389
|
-11.56%
|
✗
|
$1.7M |
| Jun 29, 2023 |
Jun 30, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
20.0
|
-9,780
|
-17.59%
|
✗
|
$869.7K |
| Mar 15, 2023 |
Mar 17, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
92.5
|
+2,949
|
5.60%
|
✗
|
$608.7K |
| Jan 13, 2023 |
Jan 17, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
26.3
|
-2,500
|
-8.27%
|
✓
|
$286.3K |
| Dec 13, 2022 |
Dec 15, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
26.3
|
-2,500
|
-8.27%
|
✓
|
$268.8K |
| Dec 2, 2022 |
Dec 6, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
26.3
|
-7,001
|
-7.76%
|
✓
|
$731.6K |
| Nov 23, 2022 |
Nov 28, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
30.0
|
-5,379
|
-5.79%
|
✓
|
$531.1K |
| Aug 5, 2022 |
Aug 9, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
22.5
|
-3,500
|
-10.23%
|
✓
|
$330.8K |
| Jul 8, 2022 |
Jul 12, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
17.5
|
-7,337
|
-19.28%
|
✓
|
$656.7K |
| Jun 29, 2022 |
Jul 1, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
26.3
|
-576
|
-1.49%
|
✗
|
$48.3K |
| Apr 29, 2022 |
May 6, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
26.3
|
-11,460
|
-9.00%
|
✓
|
$997.1K |
| Mar 15, 2022 |
Mar 17, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
95.0
|
+8,590
|
28.91%
|
✗
|
$193.2K |
| Feb 3, 2022 |
Feb 7, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
22.5
|
-1,072
|
-3.48%
|
✗
|
$94.1K |
| Jun 29, 2021 |
Jun 30, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
26.3
|
-576
|
-1.84%
|
✗
|
$48.1K |
| Apr 30, 2021 |
May 11, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
26.3
|
-6,368
|
-9.22%
|
✓
|
$533.4K |
| Apr 1, 2021 |
Apr 2, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
17.5
|
-5,692
|
-15.51%
|
✓
|
$434.3K |
| Mar 22, 2021 |
Mar 23, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
26.3
|
-516
|
-1.39%
|
✗
|
$40.5K |
| Mar 15, 2021 |
Mar 17, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
95.0
|
+8,534
|
29.75%
|
✗
|
$122.9K |
| Feb 3, 2021 |
Feb 4, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
22.5
|
-1,071
|
-3.60%
|
✗
|
$88.7K |
| Mar 20, 2020 |
Mar 24, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
26.3
|
-414
|
-1.64%
|
✗
|
$30.2K |
| Mar 13, 2020 |
Mar 17, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CFO |
Sell |
95.0
|
+5,427
|
27.45%
|
✗
|
$110.1K |
| Apr 5, 2019 |
Apr 9, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
17.5
|
-2,953
|
-17.78%
|
✓
|
$277.6K |
| Mar 22, 2019 |
Mar 26, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
26.3
|
-415
|
-2.44%
|
✗
|
$36.5K |
| Mar 15, 2019 |
Mar 19, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
95.0
|
+4,631
|
37.36%
|
✗
|
$108.6K |
| Aug 7, 2018 |
Aug 9, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
17.5
|
-2,500
|
-16.81%
|
✓
|
$261.3K |
| Jun 22, 2018 |
Jun 26, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
22.5
|
-3,145
|
-11.27%
|
✓
|
$312.9K |
| Jun 15, 2018 |
Jun 18, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
25.0
|
-2,021
|
-13.43%
|
✓
|
$191K |
| Jun 4, 2018 |
Jun 6, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
26.3
|
-346
|
-2.25%
|
✗
|
$31.9K |
| Apr 30, 2018 |
May 14, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
25.0
|
-2,163
|
-12.32%
|
✓
|
$219.3K |
| Mar 22, 2018 |
Mar 26, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
26.3
|
-414
|
-2.30%
|
✗
|
$33.7K |
| Mar 15, 2018 |
Mar 20, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
95.0
|
+5,055
|
13.38%
|
✗
|
$54.9K |
| Jun 22, 2017 |
Jun 23, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
17.5
|
-2,671
|
-17.17%
|
✓
|
$267.1K |
| Jun 2, 2017 |
Jun 6, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
26.3
|
-376
|
-2.84%
|
✗
|
$34.1K |
| May 15, 2017 |
May 17, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
26.3
|
-207
|
-1.54%
|
✗
|
$18.9K |
| Apr 28, 2017 |
May 10, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
22.5
|
-7,212
|
-13.74%
|
✓
|
$687.3K |
| Mar 15, 2017 |
Mar 17, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
SVP, Corporate Controller |
Sell |
22.5
|
-712
|
-5.08%
|
✗
|
$65.3K |
| Aug 1, 2016 |
Aug 3, 2016 |
BIOMARIN PHARMACEUTICAL INC
|
VP, Corporate Controller |
Sell |
48.8
|
-287
|
-1.97%
|
✓
|
$28.7K |
| Jun 3, 2016 |
Jun 7, 2016 |
BIOMARIN PHARMACEUTICAL INC
|
VP, Corporate Controller |
Sell |
26.3
|
-376
|
-2.52%
|
✗
|
$33.8K |
| May 13, 2016 |
May 17, 2016 |
BIOMARIN PHARMACEUTICAL INC
|
VP, Corporate Controller |
Sell |
26.3
|
-207
|
-1.37%
|
✗
|
$17.1K |